James N. Wilson - 15 Jul 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jul 2026, 18:38:28 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson

Key filing fact

James N. Wilson filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 17 Jul 2026.

Key facts

  • This page summarizes James N. Wilson's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jul 2026, 18:38.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: -$882,986.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236387 Primary reporting owner

WILSON JAMES N

Relationship
Director
Address
C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson
Signature date
17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Sale

Transaction value
$93,633
Shares
-1,079
Change %
-0.1%
Price
$86.78
Shares after
1,093,464
Date
15 Jul 2026
Ownership
James N. Wilson and Pamela D. Wilson Trust
Footnotes
F1, F2, F6
CORT transaction

Common Stock

Sale

Transaction value
$348,223
Shares
-3,969
Change %
-0.36%
Price
$87.74
Shares after
1,089,495
Date
15 Jul 2026
Ownership
James N. Wilson and Pamela D. Wilson Trust
Footnotes
F1, F3, F6
CORT transaction

Common Stock

Sale

Transaction value
$264,122
Shares
-2,974
Change %
-0.27%
Price
$88.81
Shares after
1,086,521
Date
15 Jul 2026
Ownership
James N. Wilson and Pamela D. Wilson Trust
Footnotes
F1, F4, F6
CORT transaction

Common Stock

Sale

Transaction value
$177,007
Shares
-1,978
Change %
-0.18%
Price
$89.49
Shares after
1,084,543
Date
15 Jul 2026
Ownership
James N. Wilson and Pamela D. Wilson Trust
Footnotes
F1, F5, F6
CORT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
200,000
Date
15 Jul 2026
Ownership
James N. Wilson 2025 Grantor Retained Annuity Trust
CORT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
200,000
Date
15 Jul 2026
Ownership
Pamela D. Wilson 2025 Grantor Retained Annuity Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.

Footnote F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $86.20 to $87.18 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F3

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $87.23 to $88.20 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F4

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $88.24 to $89.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F5

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $89.31 to $89.665 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F6

Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .